Evidence map›Paper›PMID 40056183›Full record

SynthesisNeuroradiology2025

Ex vivo ultra-high field magnetic resonance imaging of human epileptogenic specimens from primarily the temporal lobe: A systematic review.

Marie-Julie D K Lemmens, R H G J van Lanen, D Uher, A J Colon, M C Hoeberigs, G Hoogland, A Roebroeck, D Ivanov, B A Poser, R P W Rouhl and 7 more

Abstract readSystematic Review
In one paragraph

Synthesis in Neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Marie-Julie D K LemmensDepartment of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands. marie-julie.lemmens@maastrichtuniversity.nl.ORCID http://orcid.org/0009-0006-9546-9945
R H G J van LanenDepartment of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.
D UherDepartment of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.
A J ColonAcademic Center for Epileptology, Kempenhaeghe/Maastricht University Medical Center, Heeze/Maastricht, The Netherlands.
M C HoeberigsDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Center, PO box 5800, Maastricht, AZ, 6202, The Netherlands.
G HooglandDepartment of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.
A RoebroeckDepartment of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
D IvanovDepartment of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
B A PoserDepartment of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
R P W RouhlMental Health and Neuroscience (MHeNs) Research Institute, Maastricht University, Maastricht, The Netherlands.
P A M HofmanDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Center, PO box 5800, Maastricht, AZ, 6202, The Netherlands.
I GijselhartAcademic Center for Epileptology, Kempenhaeghe/Maastricht University Medical Center, Heeze/Maastricht, The Netherlands.
G S DrenthenDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Center, PO box 5800, Maastricht, AZ, 6202, The Netherlands.
J F A JansenDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Center, PO box 5800, Maastricht, AZ, 6202, The Netherlands.
W H BackesDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Center, PO box 5800, Maastricht, AZ, 6202, The Netherlands.
K RijkersDepartment of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.
O E M G SchijnsDepartment of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.

Funding

Epilepsiefonds 2020-09
6 · The paper itself

Abstract

purposeMagnetic resonance imaging (MRI) is the preferred diagnostic tool for the detection of structural cerebral lesions in patients with epilepsy. Ultra-high field (UHF) MRI with field strengths ≥7 Tesla has been reported to improve the visualization and delineation of epileptogenic lesions. The use of ex vivo UHF MRI may expand our knowledge on the detection and detailed micromorphology of subtle epileptogenic lesions by bridging the gap between in vivo MRI and histopathology.

methodsA systematic review of available literature was conducted following PRISMA guidelines. A descriptive analysis of included articles was performed, focusing on (I) the ability of ex vivo UHF MRI to detect subtle abnormalities related to epilepsy, (II) different post-processing methods, and (III) concordance between UHF MRI and histopathology.

resultsEleven studies with focus on the depiction of focal cortical dysplasia (n = 4) or hippocampal sclerosis (n = 7) as causative lesion of drug-resistant epilepsy were included. Ex vivo UHF MRI proved its ability to visualize the anatomy of cortical and hippocampal structures in greater detail when compared to ex vivo conventional field strengths. Different MRI post-processing methods enabled differentiation between lesional subtypes and provided novel insights into (peri)lesional characteristics. Concordance between ex vivo UHF MRI findings and histopathology was high.

conclusionAcquisition of ex vivo UHF MRI and its image processing has the potential to depict epileptogenic abnormalities in greater detail with a spatial resolution approximating histological images. The translation of ex vivo UHF MRI features to in vivo clinical settings remains challenging and urges further exploration.

Indexed as

EpilepsyMagnetic Resonance ImagingTemporal LobeHumansEpilepsyEpilepsy surgeryEx vivo imagingUHF MRIUltra-high field

Identifiers

PMID40056183
PMCPMC12041060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.